Hims & Hers Health's high P/S ratio is justified by strong f...
Hims & Hers Health's high P/S ratio is justified by strong future revenue growth. Investors are willing to pay a premium for the stock due to the company's growth potential and positive outlook.
Why Investors Shouldn't Be Surprised By Hims & Hers Health, Inc.'s (NYSE:HIMS) 48% Share Price Surge
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment